Genomenon announced today that Keck Graduate Institute (KGI) has become the first academic partner in their new Genomics Educator Program. Genomenon is the creator of the Mastermind Genomic Search Engine, which provides insight into the published genomic research for every disease, gene, and variant found in the scientific literature. Continue Reading….
Widely considered one of the most prestigious business awards programs in the U.S., the program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world. Klein was selected as a finalist by a panel of independent judges. Continue Reading….
Genomenon Inc., the leading genomic search company, today announced that Bio-IT World has awarded them Best of Show for the Mastermind Genomic Search Engine. During the April 18th awards ceremony, Mastermind was applauded as a product that was unique, important to the industry, and offered a compelling return on investment. Continue Reading….
April 16, 2019 – Genomenon Partners with Google to Make Genomic Data Available on Google Cloud Platform
Genomenon, Inc. announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud Platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big data and machine learning data warehouse, for use in genomic applications. Continue Reading….
April 2, 2019 – LifeMap Sciences and Genomenon Partner to Integrate Mastermind Genomic Search Engine into GeneCards Suite and TGex
LifeMap Sciences, the leading integrated biomedical knowledgebase company and a leading provider of tertiary NGS analysis and interpretation solutions for genetic disorders, and Genomenon, the leading genomic search company, announced today that they have entered into a partnership to improve LifeMap’s GeneCards knowledgebase and provide accelerated interpretation of genetic disorders by integrating the Mastermind Genomic Search Engine. Continue Reading….
Genomenon has been recognized as one of the 2019 “Michigan 50 Companies to Watch,” an awards program presented by Michigan Celebrates Small Business. Selected companies like Genomenon are known for their exceptional entrepreneurial leadership, creation of innovation or use of innovation in creative ways, and their sustainable competitive advantage. Continue Reading….
February 28, 2019 – Rare Genomics Institute Demonstrates the Power of Genomenon’s AI-Based Technology in Diagnosis
Rare Genomics Institute, a nonprofit providing direct support to undiagnosed rare disease patients, announced on Rare Disease Day that they were able to diagnose a previously undiagnosed patient with the use of the Mastermind Genomic Search Engine, a clinical decision support tool by Genomenon. Continue Reading….
February 19, 2019 – Genomenon and Diploid Sign Partnership Agreement to Accelerate Rare Disease Diagnostics
Genomenon and Diploid announced today that the Mastermind Genomic Search Engine has been integrated Into Diploid’s Moon diagnostic software, an advancement that will improve genome interpretation for rare disease diagnostics. Continue Reading….
Genomenon announced today that industry veteran David Anstey has joined the executive team as the company’s Vice President of Sales. In his new role, Anstey is responsible for building out and leading the company’s sales and business development efforts. Continue Reading….
January 17, 2019 – Emergence of Cancer Drug Resistance and Focus on Rare Diseases Found in 2018 Published Research
Genomenon has released a research report detailing the top emerging genomic variants in 2018. This year’s data showed a continued trend of studies and new discoveries detailing variants that are becoming increasingly resistant to drugs. The report was compiled using the research data found in the Mastermind® Genomic Search Engine. Continue Reading….
Genomenon® announced that it has completed a $2.5M equity financing round. Investors in this round include IrishAngels, H. W. Kaufman Group, and all of Genomenon’s earlier investors including the company’s CEO, Mike Klein. The company initially set out to raise $2.0M in new financing, but with strong interest from both current and new investors, the round was oversubscribed. Continue Reading….
Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The term “variant” refers to a genomic mutation in the DNA – key data used in searching for causes of cancer and rare diseases. Continue Reading….
October 29, 2018 – GenomOncology and Genomenon Partner to bring Genomic Literature Search to Molecular Tumor Board
GenomOnocology and Genomenon® announced today a partnership that incorporates Mastermind® Genomic Search Engine results into GenomOncology’s Molecular Tumor Board. The goal of the partnership is to put the most up-to-date genomic research at the fingertips of oncologists making treatment decisions for critically ill cancer patients. Continue Reading….
October 18, 2018 – Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation
Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant classification. Continue Reading….
October 16, 2018 – Genomenon Partners with Rare Genomics Institute, Begins with Philanthropic Donation
Genomenon announced today that they will donate Mastermind Genomic Search Engine licenses to the entire team of clinical scientists at Rare Genomics Institute to accelerate their work for patients with rare diseases. Continue Reading….
Genomenon, Inc. has been selected as a 2018 TiE20 Winner for the prestigious TiE20 Awards Program. The company has been recognized for its work in Next Generation Sequencing (NGS) interpretation with the Mastermind Genomic Search Engine. Mastermind assists doctors and researchers in connecting patient DNA with the most relevant medical research. The competition is a part of TiECon Detroit 2018, Michigan’s largest conference for entrepreneurs. Continue Reading….
September 18, 2018 – Genomenon Advances its Genomic Search Engine for Pharma and Diagnostic Labs with Supplemental Data
Mastermind Genomic Search Engine indexes 500,000 new genomic variants from supplemental data found in scientific publications. Researchers and clinicians can now use the Mastermind Genomic Search Engine to expand their search into the supplemental materials that are often published alongside research papers and frequently contain vast collections of genomic information. Continue Reading….
July 31, 2018 – Genomenon Awarded Phase 2 NIH Grant to Apply Artificial Intelligence to Genomic Interpretation
Genomenon, the leading genomic data search company, today announced that it was awarded a Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). Continue Reading….
June 26, 2018 – The University of Vermont Health Network Standardizes on Genomenon’s Mastermind Genomic Search Engine
Genomenon announced today that the University of Vermont Health Network has selected Genomenon’s Mastermind Genomic Search Engine as their standard for searching medical literature for variant interpretation within the Department of Pathology and Laboratory Medicine. Continue Reading….
Through the Fluidigm-Genomenon joint panel design services offering, researchers will be able to accelerate the design of disease-specific next-generation sequencing (NGS), genotyping, and real-time PCR panels for use with highly efficient Fluidigm® automated microfluidic systems. Continue Reading….
May 23, 2018 – Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels
Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies Continue Reading….
April 24, 2018 – Genomenon’s Machine Learning Algorithm Identifies Key Biomarkers for Rare Genetic Disorders of Obesity
Genomenon, the leading genomic data search company, today announced a partnership with Rhythm Pharmaceuticals, a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, to create a database of genetic mutations associated with obesity as documented in the medical literature. Continue Reading….
Mastermind Uses Machine Learning to Prioritize Medical Literature According to ACMG Variant Interpretation Guidelines Continue Reading….
April 2, 2018 – Genomenon Partners with Veritas Genetics to Create Next Generation Genomic Literature Prioritization Engine Powered By Machine Learning and AI
Companies Collaborate to Aggressively Reduce the Time and Cost of Variant Interpretation to Further Scale Global Adoption of Whole Genome Sequencing Continue Reading….
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis. Continue Reading….
The Mastermind now provides a link to VarSome for gene and variant information from 30 different genomic databases. VarSome includes a link to Mastermind search results for the scientific literature related to each variant and gene in VarSome. Continue Reading….
Genomenon Presents Details of a Pan-Hematopoietic Malignancy Gene Panel with with Supporting Evidence. Continue Reading….
October 18th, 2017 – LifeOmic Leverages Genomenon’s Mastermind Genomic Search Engine for Variant Intrepretation
LifeOmic Partners with Genomenon to Streamline Genomic Interpretation of Whole Genomes Continue Reading….
Genomenon is offering a Free Edition of the Mastermind Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis. Continue Reading….
New Product Dramatically Accelerates Genetic Variant Curation – Speeding Time to Patient Diagnosis. Continue Reading….
Genomenon Inc., a DNA interpretation software company, today announced the completion of a $1.8M investment. Continue Reading….
Genomenon’s Board of Directors recently appointed Mike Klein to the position of Chief Executive Officer as the company prepares to launch its first product, Mastermind, the worlds first genomic search engine. Continue Reading….